SM is a clonal mast cell neoplasm associated with the uncontrolled proliferation and activation of abnormal mast cells throughout the body.1-3
SM is primarily driven by the KIT D816V mutation, which is present in ~95% of cases.4-6
Indolent systemic mastocytosis (ISM) represents the largest subtype of SM6-8
A diagnosis of SM is categorized into subtypes that fall along a clinical spectrum based on disease burden, including ISM and Advanced SM.1
Challenges in recognizing SM can result in a prolonged time to diagnosis
Because of its heterogeneous and nonspecific symptoms, SM is often mistaken for other disorders.3 Receiving an accurate diagnosis can take an average of ~6 years from symptom onset.9
The delay in diagnosis is notable given the detrimental long-term effects that SM can have on patients, such as decreased overall survival from organ damage in Advanced SM.2,10